Analysis shows increased buprenorphine dispensing rates in US pharmacies, highlighting disparities in availability across neighborhoods.
From 2017 to 2023, the percentage of US pharmacies regularly dispensing buprenorphine increased from 33 percent to 39 percent. Buprenorphine availability varied substantially across states, counties, and neighborhoods, with pharmacies in low-income, Black, or Latinx neighborhoods persistently less likely to regularly dispense buprenorphine than pharmacies in other neighborhoods.
No takes yet. Share an insight, caveat, or question.
Guadamuz et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: